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ABSTRACT The polymerase chain reaction (PCR), from
primers corresponding to conserved sequences within the cat-
alytic domains of the protein-tyrosine phosphatases, was used
to amplify protein-tyrosine phosphatase-related cDNAs from a
HeLa cell library. After probing the same cDNA library with
one of the PCR products, 10 positive clones were identified. The
longest of these clones (3984 base pairs) contained 2739 base
pairs of open reading frame and, after a stop codon, a 3'
nontranslated segment of 1222 base pairs. A 4.3-kilobase
transcript was detected by Northern blot analysis of HeLa cell
poly(A)+ RNA. The open reading frame predicts a protein of
913 amino acids ("104 kDa), termed PTPH1. The sequence of
PTPH1 can be described in terms of three segments. (i) The
N-terminal segment displays homology to the domains in the
cytoskeletal-associated proteins band 4.1, ezrin, and talin that
direct their association with proteins at the interface between
the plasma membrane and the cytoskeleton in structures such
as focal adhesions. (ii) There is a central segment bearing
putative phosphorylation sites for protein-serine/threonine
kinases. (iii) A segment that is homologous to the members of
the protein-tyrosine phosphatase family is located at the C
terminus. The structure is discussed in the light of the potential
role of PIPH1 in controlling cytoskeletal integrity and the
possibility that overexpression of PTPH1 may reverse trans-
formation induced by oncogenic protein-tyrosine kinases, such
as the members of the src family.
Protein-tyrosine phosphorylation has been implicated in the
control of many cellular processes including normal and
neoplastic cell growth (1). Since the phosphorylation of
tyrosyl residues in vivo is reversible, a complete understand-
ing of its physiological significance must encompass the
characterization of the protein-tyrosine phosphatases (PTPs;
protein-tyrosine-phosphate phosphohydrolase, EC 3.1.3.48)
in addition to the protein-tyrosine kinases (PTKs; ATP:pro-
tein-tyrosine O-phosphotransferase, EC 2.7.1.112). PTP1B,
a low molecular weight PTP, was first isolated in homoge-
neous form from human placenta (2, 3). After determination
of its amino acid sequence, homology between PTP1B and
CD45 was demonstrated (4), establishing that the PTPs exist
as transmembrane receptor-like proteins as well as low
molecular weight cytoplasmic forms (for review, see ref. 5).
A cDNA for a second low molecular weight PTP, termed
T-cell PTP (TCPTP), was isolated from a human peripheral
T-cell library (6). This species has also been detected in a
variety of tissues and cell lines and is not restricted to
lymphocytes (unpublished observations). A number of stud-
ies involving low-stringency screening have identified further
PTPs that can be classified as transmembrane or receptor-like
(for review, see ref. 5). With one exception, these possess
two cytoplasmic domains that are homologous to PTP1B;
however, as yet, few of the proteins have been isolated or
expressed and shown to be active. These receptor-like PTPs
vary considerably in the structure of their extracellular
segments. For leukocyte common antigen-related (LAR)
molecules (7), the extracellular segment is homologous to
both immunoglobulin-like and fibronectin type III-like se-
quences in the neural cell adhesion molecules. This suggests
that, analogous to the neural cell adhesion molecules, ho-
mophilic interactions between LAR molecules on adjacent
cells may regulate adhesion phenomena by modulation of the
PTP activity of their intracellular segments. At the present
time, however, there are no data to suggest the identity of the
ligands for the other receptor PTPs.
Recent studies involving CD45-negative T cells have es-
tablished a requirement for CD45 in the stimulation of
antigen-induced T-cell proliferation (8), confirming that this
PTP may play a positive role in initiating signal transduction
events. In addition it has been shown that the activity of
p34cdc2, a protein-serine/threonine kinase that is required for
progression through both the G1/S and G2/M boundaries of
the cell cycle, is negatively regulated by tyrosine phosphor-
ylation (9). Dephosphorylation of a tyrosyl residue in the
consensus ATP binding site (Tyr-15) activates the kinase and
drives the cell into mitosis (9). These examples indicate that
the PTPs should not be viewed as simply providing an
"off-switch" to counter the activity ofPTKs, but rather they
are implicated in the positive regulation of a number of
fundamental cellular processes.
An essential step to understanding fully the scope of the
physiological importance of the PTPs is the identification and
characterization of the members of this family. We have
isolated a cDNA for a nontransmembrane protein from HeLa
cells that is homologous to the PTPs. Its sequencet suggests
that it may act at the interface between the plasma membrane
and the cytoskeleton, for instance at focal adhesion plaques,
and may, therefore, function in maintaining the integrity of
the cytoskeleton. In the light of its structure, the potential of
this enzyme, termed PTPH1, to reverse transformation by
oncogenic PTKs, such as src, is also discussed.
MATERIALS AND METHODS
Polymerase Chain Reaction (PCR) Conditions. Oligonucle-
otide primers were synthesized based on the conserved
amino acid sequences KCAQYWP [primer 1, equivalent to
residues 120-126 in PTP1B (10)] and HCSAGIG [primer 2,
equivalent to residues 214-220 in PTP1B (10)]. The degen-
Abbreviations: PTP, protein-tyrosine phosphatase; PTK, protein-
tyrosine kinase.
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eracy of primer 1 was 64-fold and that of primer 2 was 96-fold.
Phage DNA of a HeLa cell cDNA library (Stratagene;
catalogue no. 936201), isolated by the plate lysate method
(11), was used as template. Primers were phosphorylated
with T4 polynucleotide kinase prior to the PCR and were
added at a final concentration of 1 MM to a mixture containing
10 mM Tris-HCl (pH 8.4), 50 mM KCJ, 1.5 MM MgCI2, 0.01%
gelatin, all four dNTPs (each at 0.2 mM), 2.5 units of Taq
polymerase, and 2 Mg of phage DNA. Thirty cycles of the
PCR were performed; each was carried out at 940C for 1 min,
500C for 1 min, and 720C for 2 min. The PCR products were
analyzed on a 1% agarose gel and DNA fragments of ==0.25
kilobase (kb) were excised, eluted from the gel, subcloned
into the Sma I site of pUC118, and sequenced.
Screening of the HeLa Cell cDNA Library. The same HeLa
cDNA library was then probed with the 0.25-kb PTPH1
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product of the PCR obtained above. Plaques were transferred
to nitrocellulose filters (Schleicher & Schuell) and screened
by hybridization at 650C in a solution containing 2x SSC (lx
SSC = 0.15 M NaCI/0.015 M trisodium citrate, pH 7.0), 5x
Denhardt's solution (11), 0.1% SDS, 25 mM sodium phos-
phate (pH 8.0), 1% sodium pyrophosphate, 10%1 (wt/vol)
dextran sulfate, and denatured calf thymus DNA (12.5 Mg!
ml). The filters were washed successively at the same tem-
perature in a series of solutions containing 0.1% SDS with 4x
SSC, 2x SSC, lx 55GSC and finally 0.l1x SSC. Hybridizing
phage were plaque-purified, DNA was prepared, and cDNA
inserts were isolated and subcloned using standard tech-
niques (11). DNA sequencing was carried out by the dideox-
ynucleotide chain-termination procedure (12) using either
manufacturer's primers (United States Biochemical) or syn-
thetic oligonucleotides derived from the existing sequences.
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FIG. 1. Nucleotide and predicted amino acid sequence of PTPH1. The open box delineates the segment of homology to the N-terminal
domains of band 4.1, ezrin, and talin. The shaded box defines the segment homologous to the catalytic domains of the PTPs. In the intervening
segment, seryl and threonyl residues located in sequences bearing features of sites of phosphorylation by casein kinase II are underlined. In
addition seryl residues that display some of the features of potential sites of phosphorylation of p34cdc2 are circled.
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Data Base Search for Related Sequences. The GenBank data
base of sequence information was searched with the FASTA
program ofPearson and Lipman (13) to identify proteins with
amino acid sequence similar to PTPH1. The alignment of
similar sequences was optimized using the ALIGN program
from the National Biomedical Research Foundation, the
mutation data matrix, and a gap penalty of 10 (14). The
alignment scores are expressed in units of standard deviation
from the average background scores of 100 randomly gener-
ated sequences of the same composition (14).
Northern Blot Analysis. Total RNA was extracted from
HeLa cells and poly(A)+ RNA was selected by oligo(dT)-
cellulose chromatography (11). After electrophoresis on a
formaldehyde/agarose (1%) gel, the RNA was transferred to
a GeneScreenPlus membrane and hybridized with the -4-kb
insert of PTPH1. The hybridization and washing conditions
were as described above except that SDS was included at 1%.
RESULTS
To identify the complement of PTPs in HeLa cells, a model
system for the study of the cell cycle, we utilized the PCR and
primers corresponding to conserved segments within the
catalytic domains to amplify PTP-related cDNAs from a
HeLa cell library. The PCR products (a0.25 kb) were sub-
cloned into pUC118; of77 independent subclones sequenced,
15 corresponded to a PTP isoform termed PTPH1. A total of
4.2 x 106 phage plaques from the same HeLa cell cDNA
library were probed with the PCR product and 10 positive
clones were identified. The sequence of the longest clone
(3984 base pairs) is presented in Fig. 1. The open reading
frame, from the first available ATG, is 2739 base pairs, which
would encode a protein of 913 amino acids with a predicted
molecular mass of a104 kDa. Although the sequence sur-
rounding the putative initiator does not conform well to the
Kozak consensus sequence (15), there is a purine at position
-3 that is an important requirement for an initiation site.
Furthermore, translation of RNA, synthesized from PTPH1
cDNA in a reticulocyte lysate, yielded a protein of a:a 120 kDa,
close to the expected size (data not shown). There is a 3'
nontranslated segment of 1222 base pairs; however, the
- 9.5 Kb
- 7.5 Kb
- 4.4 Kb
- 2.4 Kb
- 1.4 Kb
FIG. 2. Northern blot analysis of PTPH1 mRNA. Approximately
10 ,ug of poly(A)+ RNA from HeLa cells was subjected to electro-
phoresis on a formaldehyde/agarose gel and transferred to a Gene-
ScreenPlus membrane. After hybridization and washing, the mem-
brane was exposed to film for 7 days at -70°C with intensifying
screens. Numbers on the right indicate the positions ofRNA markers
(BRL).
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cDNA contains no consensus polyadenylylation signal or
poly(A) tail. A transcript encoding PTPH1 was detected by
Northern blot analysis of HeLa cell poly(A)+ mRNA, as a
low-abundance message of -4.3 kb (Fig. 2). The slightly
larger size of the mRNA may be explained in part by the
absence of a poly(A) tail in the cDNA.
A search of the GenBank data base, using the Pearson and
Lipman FASTA program (13), confirmed the similarity in
sequence between the C-terminal segment of PTPH1 and the
catalytic domains of the members of the PTP family. This is
depicted in Fig. 3A. Although the tyrosine phosphatase
activity of PTPH1 remains to be demonstrated, it should be
noted that in CD45 (16) and LAR (17), which share compa-
rable levels of sequence identity to PTP1B as displayed by
PTPH1, intrinsic activity has been confirmed.
A comparison of the sequence of the N-terminal 650
residues of PTPH1 with those in GenBank demonstrated
similarity between residues 30 and 357 and the homologous
N-terminal domains in band 4.1, ezrin, and talin that are
believed to be important for localizing these proteins to
junctions between the plasma membrane and the cytoskele-
ton (Fig. 3B).
Using the ALIGN program, the N- and C-terminal segments
of PTPH1 were compared separately with each of their
related sequences. The alignment scores presented in Tables
A
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FIG. 3. Alignment of amino acid residues of PTPH1 with the
conserved domains in related proteins. (A) The sequence of the
PTP-like domain in PTPH1 is compared with the catalytic domains
of two low molecular weight PTPs, PTP1B (PTPase 1B) and TCPTP
(T-cell PTPase), and a receptor-linked form (CD45). (B) The se-
quence of the N-terminal segment PTPH1 is compared with the
homologous domains in band 4.1, ezrin, and talin. Only identities
between PTPH1 and the other sequences have been highlighted and
gaps (denoted by hyphens) have been inserted to optimize the
alignment.
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Table 1. Evidence of homology between PTPH1 and members of
the PTP family
PTPH1 PTP1B TCPTP CD45 DI CD45 DII
PTPH1 - 24.8 30.2 23.4 17.6
PTP1B 39% - 50.8 23.8 16.4
TCPTP 42% 73% - 23.9 16.4
CD45 DI 37% 35% 36% 20.6
CD45 DII 30% 31% 32% 35% -
Numbers above the diagonal express the similarity between seg-
ments in terms of their alignment scores. Residues 669-900 in PTPH1
were compared pairwise with residues 40-276 in PTP1B, 42-274 in
TCPTP, 491-725 in CD45 domain I (DI), and 782-1041 in CD45
domain II (DII) (10). Scores greater than 5 are indicative of homol-
ogy. Numbers below the diagonal represent the percentage identity
expressed as the number of identities out of possible matches
between residues in the aligned sequences depicted in Fig. 3.
1 and 2 establish clearly that the sequence similarities are
indicative ofa homologous relationship. The lowest degree of
structural similarity was observed in the comparison of the
N-terminal segment ofPTPH1 with the homologous structure
in murine talin; in this case the species difference may
contribute to reducing the alignment score. The sequence of
human talin was not available for comparison.
The intervening central segment of PTPH1 (residues 358-
668) did not display homology with any sequence in the data
base. However, a number of putative phosphorylation sites
are found in this segment. The primary structure require-
ments for phosphorylation by casein kinase II include the
presence of acidic residues surrounding the phosphorylated
serine or threonine. An aspartic or glutamic acid three
residues to the C terminus of the phosphate acceptor site is
particularly crucial (18). The presence of prolyl residues
preceding the phosphorylation site is also common. Six
potential sites are indicated in Fig. 1. In addition, seryl or
threonyl residues phosphorylated by p34cdc2 are immediately
followed by a prolyl residue, frequently in a sequence,
Pol-Ser/Thr-Pro-Xaa-Bas (where Pol is a polar residue and
Bas is a basic residue) (19). Ser-372, -381, and -435 display
some of these features. It will be of interest to ascertain
whether these sites are phosphorylated and the effect of
phosphorylation on activity.
DISCUSSION
The structure ofPTPH1 is summarized in Fig. 4. Its sequence
implies that PTPH1 may act at junctions between the mem-
brane and the cytoskeleton, such as in focal adhesions. Focal
adhesion plaques are specialized regions of the plasma mem-
brane through which cells in culture adhere to the external
substrate (22). On their internal face these structures anchor
actin stress fibers, which are important in determining cell
shape. Within focal adhesions, the integrins provide the
transmembrane link between components ofthe extracellular
matrix, such as fibronectin and vitronectin, and the cytoskel-
eton. Their intracellular segments interact indirectly with
actin cables through a multiprotein complex. Talin interacts
with the cytoplasmic segment of the integrin p chain and also
Table 2. Evidence of homology between PTPH1 and members of
the talin family of cytoskeletal-associated proteins
PTPH1 Band 4.1 Ezrin Talin
PTPH1 33.5 17.5 9.9
Band 4.1 37% - 18.9 7.5
Ezrin 27% 29% 9.1
Talin 20% 16% 16%
Residues 30-357 in PTPH1 were compared pairwise with residues
2-323 in band 4.1 (37), residues 4-339 in ezrin (39), and residues
120-455 in talin (36). See Table 1 for other details.
binds to vinculin. Vinculin has been shown to interact with
a-actinin, which can bind actin directly (for review, see ref.
22). However, this picture is undoubtedly incomplete. Mi-
crotubules and intermediate filaments may also terminate at
focal adhesions, but the nature of the proteins that facilitate
this interaction is unknown. Furthermore, similar but less-
characterized structures have been implicated in attachment
between neighboring cells and adherence to the extracellular
matrix in vivo. Thus, additional focal adhesion-associated
proteins remain to be described and their functions remain to
be established.
Oncogenic transformation is frequently associated with a
less-adherent rounded cellular morphology that results from
a disruption of cytoskeletal integrity and reduction in the
number of focal adhesions (23). Furthermore, residual adhe-
sion plaques are invariably associated with the transforming
PTK, for example, src, yes, or abl (23). In Rous sarcoma
virus-transformed cells, for instance, it has been postulated
that a contributing factor to the generation of the transformed
phenotype is the aberrant phosphorylation by pp6v-src of
tyrosyl residues in key focal adhesion proteins (24-28). The
phosphorylation oftyrosyl residues has been demonstrated in
the P subunit of integrin (27), vinculin (29), talin (30), ezrin
(31), and paxillin (32). Although a correlation has yet to be
established between such phosphorylation and the appear-
ance of the morphology of a transformed cell, evidence is
accumulating to suggest that phosphorylation of the integrin
,p subunit is important in this regard (33). Staining with
antibodies to phosphotyrosine has indicated that tyrosine
phosphorylation of focal adhesion (34) and apical junction
(35) proteins also occurs in nontransformed cells, suggesting
that PTKs act at these sites during normal cell function.
However, the kinases involved have yet to be identified. In
view of the potentially disastrous effects of aberrant tyrosine
phosphorylation, it is expected that the activity of these
PTKs is tightly controlled. The localization of a PTP to these
structures is one means by which such regulation could be
achieved. We propose that PTPH1 may perform such a
function.
Protein and cDNA sequence analyses have defined a
family of proteins, including talin (36), band 4.1 (37), and
ezrin (38, 39), that participate in the interaction between the
membrane and cytoskeleton. They possess a homologous
N-terminal domain that appears to associate with protein
components in the plasma membrane. In band 4.1, which
M 375 3
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FIG. 4. Schematic diagram illustrating the structure of PTPH1
and its relationship to other proteins. PTPH1 comprises three
segments: an N-terminal segment (shaded box) with homology to the
membrane localization domains in band 4.1, ezrin, and talin, a
putative regulatory segment in the middle of the protein (open box),
and a C-terminal PTP-related segment (solid box). TM denotes the
transmembrane domain in CD45. The length of each protein is shown
in proportion to the number of amino acid residues. For PTP11B, the
full-length 435-residue protein (20, 21) is depicted. The molecule
originally isolated from human placenta (2, 3) was a C-terminally
truncated form. The homology among domains is indicated by
percentage identity. The segments are defined in the legend to
Table 1.
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promotes association of actin and spectrin in erythrocytes,
this domain interacts with the transmembrane protein glyco-
phorin (40). A similar model has been proposed for the
interaction of talin with integrin (36). For ezrin, which
displays a submembranous localization in brush border cells,
the details of its interaction with other proteins remain to be
established. The presence ofa homologous domain in PTPH1
suggests that this PTP will also be located in submembranous
structures, such as focal adhesions, where it may modulate
the level of phosphotyrosine in proteins.
Considering the apparent correlation between Rous sar-
coma virus-induced transformation and the cytoskeletal as-
sociation of pp60src (24-28), we propose that PTPH1 is also
an excellent candidate PTP with which, through overexpres-
sion, to achieve a reversion of src-induced transformation
and, furthermore, to delineate the precise role of tyrosine
phosphorylation in the morphological changes induced by
src. In addition this PTP clearly has potential to function as
a growth suppressor. It has been noted that treatment of
NRK cells with vanadate, the actions of which include the
inhibition of PTPs, enhanced the level of cellular phospho-
tyrosine and lead to production of a transformed phenotype
(41). Thus, the inactivation or deletion of PTPH1 could
conceivably in itself be sufficient to generate a transformed
cell.
The PTPs form a rapidly expanding family (5) and it is
anticipated that the various isoforms will have specific func-
tions in vivo. The structure of PTPH1 may illustrate a general
theme among the PTPs; within the protein, distinct structural
motifs may, at least in part, control specificity by restricting
intracellular localization. We propose that PTPH1 acts at thejunction between the cytoskeleton and the plasma membrane
and plays a role in controlling cytoskeletal integrity. The
occurrence of a signal peptide sequence and a transmem-
brane domain in CD45 directs it to span the membrane (4).
The C-terminal noncatalytic segment of the low molecular
weight cytoplasmic PTPs also appears to direct association
with the particulate fraction of cell extracts (42). In addition
such structural motifs may determine how the activity of the
catalytic domain is controlled. Thus, for the receptor-like
forms the binding of ligands to the extracellular segments
may modulate activity. The C-terminal segment of the low
molecular weight PTP appears to repress the activity of the
catalytic domain (42). If PTPH1 is localized to focal adhe-
sions, it should also be regulated to permit normal tyrosine
phosphorylation at such sites in nontransformed cells. Phos-
phorylation of serine/threonine residues in the central seg-
ment of the protein (Fig. 1) may directly modulate activity. In
addition, by analogy with band 4.1 whose affinity for glyco-
phorin is regulated by phosphatidylinositol 4,5-bisphosphate(43) it is possible that the localization of PTPH1 may be
altered with phosphatidylinositol turnover.
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